v3.24.3
Collaboration, License, and Other Agreements - Amounts Recognized in Statement of Operations with Roche (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Disaggregation of Revenue [Line Items]        
Revenues $ 3,720.7 $ 3,362.7 $ 10,412.8 $ 9,682.9
Ronapreve | Roche Collaboration Agreement | Collaboration revenue        
Disaggregation of Revenue [Line Items]        
Revenues 0.5 0.0 1.4 222.2
Other | Roche Collaboration Agreement | Collaboration revenue        
Disaggregation of Revenue [Line Items]        
Revenues $ 0.0 $ (5.7) $ 0.0 $ (9.5)